Regulation - Pharmaceutical, aflibercept

Filter

Current filters:

Pharmaceuticalaflibercept

Popular Filters

Bayer to file for EU approval of aflibercept for central retinal vein occlusion

21-02-2012

German drug major Bayer (BAY: DE) says that it will file for European approval of its macular edema treatment…

afliberceptBayerEuropeEyleaOphthalmicsPharmaceuticalRegeneronRegulationResearch

Back to top